Venky Profile
Venky

@venkymd

Followers
5,957
Following
4,572
Media
159
Statuses
1,137
Explore trending content on Musk Viewer
@venkymd
Venky
2 years
Reason for rejection of a RCT manuscript done in India. Reviewer. 1. Reported survival is low (which is the reality). 2. Hi fi molecular testing not performed (expensive and not available). When will 10% of the world realize the reality of 90% of the world. #GlobalOncology
36
115
707
@venkymd
Venky
2 years
Dear Sir @narendramodi @PMOIndia @mansukhmandviya @MoHFW_INDIA Every year about 77, 000 children with cancer are diagnosed in India. Which is 20% Global burden. Only 26,000 (34%) reach a cancer centre. Kindly requesting you to include pediatric cancer in national cancer policy.
7
133
365
@venkymd
Venky
2 years
Oncologists in LMIC should stop prescribing a neutropenic diet to cancer patients. Our study shows it does not reduce infection. @BMJ_SPCare @CI_WIA Neutropenic versus regular diet for acute leukaemia induction chemotherapy: randomised controlled trial
36
74
254
@venkymd
Venky
2 years
Academic twitter I need some motivation. Completed 2 large investigator initiated RCTs one of them multicenter. Trial 1 rejected by 7 journals despite positive reviews. Trial 2 rejected by top journal in the field. Both selected only as posters in international conferences.
30
24
178
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 The top cancer centers from India Cancer Institute Chennai TMC Mumbai AIIMS New Delhi PGI Chandigarh have presented practice changing data at the International level
8
14
173
@venkymd
Venky
2 years
📖 Our multi-centre study: 2 drug vs 3 drug induction in pediatric acute myeloid leukemia ✅ No benefit in survival with addition of 3rd drug etoposide (ADE) to dauno and ARAC (3+7) ✅ Similar toxicities ✅ First INPHOG RCT ✅ First RCT on AML from LMIC
24
43
155
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Me presenting our study on dexamethasone free antiemetic regimen
Tweet media one
6
12
149
@venkymd
Venky
1 year
I have been in oncology for close to 15 years but never attended a major international conference like @ASCO or @myESMO . This is my first ASCO meeting. I will try to highlight the studies from resource limited setting as these are rarely given the importance they deserve #ASCO23
8
6
142
@venkymd
Venky
2 years
✅ 80% of pediatric cancers occur in LMICs 20% in HICs ✅ 20% of pediatric cancer survive in LMICs 80% in HICs ❌ 80-90% of oral presentations in conferences are from HICs 10%-20% from LMICs How will we improve survival in LMICs to 60% by 2030 if their voices aren't heard
9
31
124
@venkymd
Venky
11 months
Female sex is the most important factor for treatment abandonment in pediatric patients with cancer treated at AIIMS New Delhi. @drsameerbakhshi #SIOP2023 #SIOPambassador
8
24
116
@venkymd
Venky
2 years
Thank you @ConquerCancerFd for awarding me and @CI_WIA the prestigious international innovation grant. The grant will help us in improving patient care, outcomes and conducting innovate research. @ASCO @stjudegraduate @StJudeResearch
@ConquerCancerFd
Conquer Cancer, the ASCO Foundation
2 years
Congratulations to the 2022 recipients of the Conquer Cancer International Innovation Grant (IIG): @drdharmapoonia , @FrancineKouya , Venkatraman Radhakrishnan, MD, MBBS, MSc, DM, @AsimaMukhopadh1 , and Regi Jose, DPH, DNB, MD, MPhil, MBBS.
8
10
49
38
10
109
@venkymd
Venky
10 months
Please vote for @cspramesh The most deserving candidate to represent the Global Oncology community in ASCO
@shhovsepyan
Shushan Hovsepyan
10 months
Thrilled to hear about Dr. @cspramesh ’s nomination to the #ASCO Board of Directors. His dedication and visionary approach are truly commendable. I feel privileged to have learned from him during @credoworkshop . Big-time congratulations on this achievement🌟 #ASCO #leadership
Tweet media one
13
21
101
4
21
105
@venkymd
Venky
1 year
#ASCO23 is nothing less than once in a life time pilgrimage for professionals from resource limited settings. Many hurdles to clear Visa Long flights Immigration questioning Financial drain: visa fees, abstract fees, registration, flights, accommodation, transportation, food
4
16
95
@venkymd
Venky
1 year
Poster presentation at a big meeting like #ASCO23 can be humbling. You go with the idea that your research is path breaking and exciting, only to realize that most don't share your enthusiasm. It's just you and your poster and no one turns up. Sitting all alone you reflect
11
9
91
@venkymd
Venky
2 years
"The most important drug for improving survival in pediatric oncology in resource limited settings and LMICs is NUTRITION." Quote: self. Our data has consistently shown across all pediatric cancers, malnutrition reduces survival by 10-30% #oncology #nutrition
1
27
88
@venkymd
Venky
1 year
Finally @asco daily news highlights a practice changing study from Global South on the last day. Congratulations @batraatulmd and team. #ASCO23
Tweet media one
3
13
88
@venkymd
Venky
1 year
Every study presented @asco meeting should have a mandatory slide that informs about the following. 1. Percentage of patients across the world likely to get the drug. 2. Financial toxicity. 3. Number needed to treat. #ASCO23
4
14
81
@venkymd
Venky
3 years
@anandoncologist She is the 5th pediatric cancer survivor in the last decade from Cancer Institute who has got admission to a medical college.
2
6
80
@venkymd
Venky
2 years
Hakka noodles and chilly paneer for dinner by yours truly. Cooking for others is a great stress buster.
Tweet media one
6
1
75
@venkymd
Venky
3 years
Doing Surya namsakar is more than just a warm up. A round of 12 Surya Namaskar can leave you exhausted. I have done them and can definitely say they are a full body work out and not just warm up. What do you say @anandoncologist @VijayRChari
@theliverdr
TheLiverDoc
3 years
Yoga is just the warm up you do before a whole good work out If you have been doing only Yoga, you have been only warming up for a very long time Yoga is not "therapeutic", it is just "pleasing" 🧘🐍🦆🧘
72
46
342
5
7
68
@venkymd
Venky
1 year
My impressions about @asco meeting. It is an amazing meeting. Everyone oncologist should attend it once in their life time. However, will I comeback again. No, I won't because. 1. It is expensive 2. It is exhausting 3. You can get the same information sitting at home #ASCO23
9
3
74
@venkymd
Venky
11 months
Pearls from Scott Howard for high dose Methotrexate. 1. Don't give furosemide. 2. Ensure urine PH maintained at 7. 3. If it drops to 6 then stop MTX, give bicarb and fluid bolus till PH 7. 4. If patient vomits give bicarb and fluid bolus. 5. MTX up to 80 gm given safely #SIOP2023
5
11
74
@venkymd
Venky
11 months
I will be posting about the #SIOP2023 meeting this week. If you are interested in pediatric oncology stay tuned. If not you can mute me for a while. Why shouldn't anyone be not interested in pediatric oncology? I will mainly focus on research from Global south #siopambassador
2
11
73
@venkymd
Venky
1 year
Collaborative studies between North America and Europe in pediatric ALL is not International collaboration. Involving Asia, Africa and Latin America will make it international because 90% of pediatric ALL is diagnosed here. #ASCO23
1
15
70
@venkymd
Venky
1 year
Our paper got rejected by a journal because the reviewers felt we used a sub standard comparator arm. The NCCN guidelines recommends the comparator arm as a standard of care (level 1) and this is most widely used in LMIC. Is the NCCN recommending sub standard regimens? #ASCO23
3
6
63
@venkymd
Venky
2 years
Thank you @DrVijayPatil11 for participating in the journal club on low dose nivolumab paper. Probably the first journal club where the PI was called on the phone to answer questions. The faculty and residents benifitted a lot.
4
2
62
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Me presenting the dexamethasone for fatigue study
Tweet media one
1
3
62
@venkymd
Venky
2 years
What more do investigators in LMICs need to do to prove themselves to the world? Why should I continue doing research? Why preach in big journals that RCTs should be encouraged in LMICs? Retrospective studies from HICs get oral presentation but not RCTs in LMICs. #MedTwitter
9
7
52
@venkymd
Venky
1 year
I have been tweeting like a kid who has got a new toy. I will be back in to twitter hibernation once I get back to work this week. So bare with me for few more days. My goal is to highlight the achievements and challenges in LMICs. We need to have a place at the table #ASCO23
4
0
59
@venkymd
Venky
11 months
Weight loss due to cancer cachexia cannot be reversed by increasing calorie intake #SIOP2023 #SIOPambassador
3
5
56
@venkymd
Venky
1 year
Journals overlook poor control arms in pharma sponsered trials but reject good investigator initiated trials for trivial reasons. Especially if the investigator initiated trials are from LMICs. #ASCO23
5
7
55
@venkymd
Venky
2 years
I will be tweeting from my account and @SIOP_Young_LMIC during #SIOP2022 . Some of your twitter time lines are going to get flooded with pediatric oncology news for the next 4 days 🙂. #siopambassador
4
6
55
@venkymd
Venky
2 years
Dear @MDAndersonNews the information provided here is partially incorrect. There is no neutropenic diet. Patients need to follow a food safety guidelines diet. Patients with neutropenia need not avoid fruits and vegetables as mentioned. There is enough evidence to support this.
@MDAndersonNews
MD Anderson Cancer Center
2 years
Did you know the foods you eat and how they’re prepared can help reduce your risk of infection? Learn the ins and outs of a neutropenic diet from clinical dietitian Sheila Vo: #NeutropenicDiet #EndCancer
0
3
6
5
14
51
@venkymd
Venky
2 years
Journals that reject recommend to send to another journal that is open access but will cost 5000 dollars. It is like rubbing salt in the wound for a LMIC investigator.
9
6
47
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Dr Atul Batra presenting diclofenac cream for hand foot syndrome
Tweet media one
Tweet media two
2
13
53
@venkymd
Venky
11 months
A lot of people including the amazing @DrGauravNarula couldn't make it to #SIOP2023 due to visa issues. A major barrier for global south to be involved in policy making and sharing their research is that we are denied opportunities to present our work due to visa denials.
5
15
51
@venkymd
Venky
1 year
How much does it cost to attend ASCO from a resource limited settings. Let's take an example if you are attending from India. Visa: 150$, Flights: 1500$, Hotels and food: 1400$, Registration: 350$, transport: 200$. Total: 4000$. #ASCO23
6
5
51
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Dr Vanita Noronha TMH presenting her study on patient navigation in lung cancer
Tweet media one
5
5
51
@venkymd
Venky
1 year
Yes, we can omit dexamethasone for CINV prophylaxis for highly emetogenic chemotherapy. CINV POD (prophylaxis omitting dexamethasone) study results are out. #ASCO23 OPF (olanzapine, palonosetron and fosaprepitant) should be a standard of care.
@venkymd
Venky
1 year
Can we omit dexamethasone as an antiemetic for highly emetogenic chemotherapy? #ASCO2023 #ASCO23
2
7
12
2
12
49
@venkymd
Venky
2 years
A debate on whether it is ethical to use adapted treatment in low and middle income countries should have representatives from LMICs. All speakers are from High income countries #globalhealth Opinions from people working on the ground is important @DrGauravNarula @deepakbansaldr1
@WorldSIOP
SIOP International
2 years
📢 We invite you to this year's debate at #SIOP2022 . 🎙️We will debate whether it is ethical to give adapted treatment in low and middle income countries. Do you want to learn more about the session? - Register and join us ➡️ #ChildhoodCancer
Tweet media one
0
17
35
7
12
47
@venkymd
Venky
1 year
The pilgrimage is incomplete without meeting the God of Medical Oncology Prof Larry Einhorn #ASCO23
Tweet media one
2
2
47
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Dr Rushab Kothari presenting an important study. OMC is the standard of care in relapsed refractory HN cancer. This should have been a plenary presentation @VanitaNoronha @DrVijayPatil11
Tweet media one
1
11
45
@venkymd
Venky
2 years
I am sorry if I have flooded your time line with my tweets. There are so many people across the world who are doing amazing and selfless work to improve outcomes in pediatric cancers. Their work needs to highlighted and appreciated. @WorldSIOP is a global community. #SIOP2022
2
4
43
@venkymd
Venky
3 years
Wonderful tribute by Dr T G Sagar Director Emeritus Cancer Institute (W.I.A) Chennai for Dr Shanta on her first death anniversary. @CI_WIA
1
16
42
@venkymd
Venky
1 year
Reduction in chemo dose intensity by 25% and adding Rituximab improves survival in pediatric high grade B Non Hodgkins Lymphoma in resource limited settings. Outcomes comparable to high income countries. A 25% improvement in survival compared to past.
2
12
43
@venkymd
Venky
1 year
If I had the money, I would do these studies 1. IMnotPOWER: Immunotherapy versus oral metronomic chemotherapy. 2. LOCKnote: standard dose immunotherapy versus low dose immunotherapy 3. UncheckMate: Repeat all positive immunotherapy trials to ensure they were not flukes. #ASCO23
2
6
43
@venkymd
Venky
1 year
A study on pembro in cervical cancer recruits patients from across the world except India, a country which contributes to the most cervical cancer cases and deaths. #ASCO23
5
4
41
@venkymd
Venky
2 years
Sex disparity in pediatric cancer care in India. Hospital and population-based registry data for 30000 pediatric cancer patients. First of its kind study from India. ❌Bias towards diagnosis in boys More in North India. @drsameerbakhshi
4
15
41
@venkymd
Venky
2 years
Pediatric cancers are not part of national cancer policy. Less than 20% of children with cancer in India survive compared to 80% in high income countries. The WHO goal of 60% survival worldwide by 2030 can be achieved only if India takes the lead. @WorldSIOP @InPOG_ @pho_india
1
11
40
@venkymd
Venky
3 years
The Indian Journal of Medical and Pediatric Oncology (IJMPO) is planning a global health issue. I would invite you all to contribute papers to the issue. It could be a commentary, review, policy brief or an original research on global health oncology. Please DM me if interested
2
3
39
@venkymd
Venky
1 year
about life, research and your purpose. You still feel happy deep inside. A sense of achievement for doing research and get motivated to start all over again. Maybe next time people will notice and you can truly make a difference. #ASCO23
3
2
39
@venkymd
Venky
2 years
A proud moment when your former fellow (registrar), mentee and friend @bhaskarlp1 is presenting his Neutropenic diet RCT at #SIOP2022 #siopambassador
Tweet media one
2
1
39
@venkymd
Venky
11 months
So proud to see my dear friend @DrBivas in @NEJM #AIIMS
Tweet media one
2
4
38
@venkymd
Venky
2 years
Retrospective studies published in journals but prospective RCT that have not be done before and practise changing not considered worthy of publication. #AcademicTwitter
2
5
33
@venkymd
Venky
1 year
It ain't international or global if it doesn't involve Asia, Africa and Latin America. #ASCO23
0
4
34
@venkymd
Venky
11 months
It was a wonderful #SIOP2023 #SIOPcongress #SIOPambassador Lots of great science Wonderful to see Global Health take the center stage. All Global Health Network sessions had full attendance. I will go back in to hibernation till the next conference Vanakam Namaste
0
2
35
@venkymd
Venky
1 year
CINV POD STUDY #ASCO2023
Tweet media one
1
7
36
@venkymd
Venky
1 year
Some off target benefits of attending #ASCO23 1. Weight loss due to walking long distance. 2. Improved decision making. Difficult to choose which session to attend. 3. Improved patience. Standing in Starbucks queue for one hour. 4. Opportunity to see oncology superstars.
3
2
36
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Dr Anant from TMH @AnantRamaswamy Concurrent capecitabine RT in ca gall bladder
Tweet media one
1
5
34
@venkymd
Venky
2 years
Saturday night play list Maroon 5: girl like you. My heart is a stereo Coke studio: Hawa Hawa Vidya Vox: O Sanna Imagine dragons: believer Eminem: lose yourself Green day: basket case Adele: Hello What are you listening to
9
1
33
@venkymd
Venky
2 years
Even if someone manages to conduct research in LMICs against all the odds, they still have to struggle to get a platform to amplify their research. Most top international journals wouldnt publish their research. #EditorialBias #ReviewerBias #FinancialBias
@cancerandcrisis
Institute of Cancer and Crisis
2 years
" #Cancer #research currently is heavily skewed toward high-income countries (HICs), with little research conducted in, and relevant to, the problems of #LMICs ". Read the full article: 👇🏻
3
8
20
6
3
31
@venkymd
Venky
1 year
Almost all the oral presentations at #ASCO23 are on immune check point inhibitors. Most showing PFS or DFS benefit, very few showing OS benefit. Questions are. 1. Can we achieve same results with lower dose. 2. Longer duration between cycles.
2
5
32
@venkymd
Venky
11 months
David vs Goliath @KBommannan presenting at #SIOP2023 in the ALL session. The other talks were from COG and Chinese leukemia group. A proud moment for @CI_WIA
Tweet media one
3
2
33
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Dr Navneet Singh from PGI Chandigarh presenting on polymorphism is lung cancer @ns_chd
Tweet media one
0
3
33
@venkymd
Venky
2 years
This is the ✅Largest RCT on a neutropenic diet 🍎 🍊🍇🍒🍌🍍🍅 ✅First RCT from LMIC ✅First RCT to explore the effect of diet on stool colonization ✅First RCT to report on outcomes ✅First to include adult and pediatric participants Thank you @Cankidz for the support.
5
6
30
@venkymd
Venky
1 year
A big issue for access to cancer medicine in LMICs is that many private hospitals profit from medicines. The purchase price of hospitals is sometime 20% of the price the patient pays. It's a free market, if government intervenes then many hospitals will shut down. #ASCO23
3
6
31
@venkymd
Venky
1 year
Go to sessions by presenters from resource limited settings. It is a great achievement that they are presenting despite all the biases. Their research is most likely to be practice changing for you and more likely to have a larger margin of benefit. #ASCO23
1
0
31
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Dr Vanita speaking on oral cancer
Tweet media one
0
6
28
@venkymd
Venky
1 year
When delivering chemotherapy the cost of daycare bed, syringes, gloves, needles, IV sets, cannula, pre medications including anti emetics and administration charges are equal to or if not more than the cost of chemo. Access to medicine should also look at these #ASCO23
2
5
28
@venkymd
Venky
11 months
Does IVIG prophylaxis reduce infections in pediatric patients with ALL. Phase 3 RCT IVIG once in 3 weeks No benefit with use of IVIG for reducing infections in induction and consolidation but beneficial in maintenance. No impact on survival and relapse #SIOP2023 #SIOPambassador
0
4
28
@venkymd
Venky
1 year
It was a great honor and privilege to meet @Winette_vdGraaf Eortc president at #ASCO23 . Looking forward to EORTC and India collaborations.
Tweet media one
1
0
27
@venkymd
Venky
1 year
4. Twitter provides great info. All sessions are available online. It makes sense to attend again if you have a oral presentation or are getting an award. This is from a resource limited perspective. #ASCO23
2
0
27
@venkymd
Venky
11 months
Fosaprepitant is inferior to aprepitant for control of acute chemotherapy induced vomiting in pediatric patients receiving highly emetogenic chemotherapy. Presented by @drsameerbakhshi #SIOP2023 #SIOPambassador
0
6
26
@venkymd
Venky
11 months
Blina prior to CD19 CART. Those who didn't respond to blina did worse. Those who had CR with blina and then relapsed has similar outcome to those who didn't receive blina. MLL gene doesn't respond to blina. #SIOP2023 #SIOPambassador
Tweet media one
1
7
24
@venkymd
Venky
2 years
Please make childhood cancer a notifiable disease.
1
6
24
@venkymd
Venky
2 years
What do you do in resource limited settings, where it is a challenge to treat patients with cancer. #SIOP2022 #siopambassador
Tweet media one
0
5
25
@venkymd
Venky
1 year
Imposter syndrome when you see thousands oncologists around you doing cutting edge science. Well dressed, confident women and men all around you. But you finally made it and you deserve it. Live the @asco moment you might not get another chance. #ASCO23
3
0
26
@venkymd
Venky
1 year
There is no house without a foundation, no car without tyres the same is for oncology there is no treatment with out supportive care. About 20 people attending the #ASCO23 supportive care session. Is it so routine that it doesn't excite oncologists
1
4
25
@venkymd
Venky
11 months
T ALL is a heterogeneous disease there are 15 different genomic subtypes Majority of alteration in T ALL is in non coding region. Whole genome sequencing required. #SIOP2023 #SIOPambassador
1
3
25
@venkymd
Venky
1 year
"Vaango" (Tamil for please come) to poster board 480 and 495 today between 1.15 pm and 4.15 pm to see our small contributions to science that will hopefully improve patient care. #ASCO23 #supportivecare .
3
4
25
@venkymd
Venky
2 years
The #siopambassador . What a wonderful bunch of diverse individuals. @venkymd is jumping in air to appear in the photo.
Tweet media one
2
1
25
@venkymd
Venky
3 years
Inviting Oncology trainees and recently graduated (less than 5 years since completion of fellowship) to join the SIOP Global Health Young (LMIC) Working Group. Let's encourage research and participation from LMICs @WorldSIOP @youngsiop @AsiaSiop @StJude
0
6
24
@venkymd
Venky
11 months
CART in high risk cytogenetics. No difference in survival due to cytogenetics risk factors. CART overcomes poor prognosis cytogenetics in ALL #SIOP2023 #SIOPambassador
Tweet media one
0
3
24
@venkymd
Venky
1 year
I met @OphiraG in my first 5 minutes of #ASCO23 . I got invited to the Access to essential care in Medicine meeting. It is not in the agenda, but it is an amazing session. It was worth skipping the other sessions I had planned. @StJude will fund 200 million dollars for medicines.
3
4
24
@venkymd
Venky
1 year
adding CRSF. Watch out for the collaboration. They are going to bring out high impact studies
0
0
22
@venkymd
Venky
1 year
#IndiaAtAsco #ASCO23 Dr Aditya TMH Mumbai presenting on neoadjuvant chemotherapy in oral cancer
Tweet media one
1
6
24
@venkymd
Venky
3 years
Congratulations @lisamforce and team for this important publication in @TheLancetOncol on the Global Burden of adolescent and young adult cancer. It was a great learning experience for me to be involved with this paper.
4
2
24
@venkymd
Venky
1 year
Poster session at #ASCO23 are like school or college. There is the popular cool person around whom everyone likes to hang around. Then there is the shy introvert person who yearns that someone will come and talk to them, briefly meeting eyes with you when you walk past them.
0
2
23
@venkymd
Venky
1 year
India has to be a potential leader in the field of access of cancer medicine in resource limited settings. We did it for HIV. Close pharma and government interaction can make this happen. #ASCO23
3
3
23
@venkymd
Venky
2 years
Carlos Rodriquez Galindo. A legend, an inspiration, a great leader and a fantastic person receiving the City Award. @stjudegraduate #SIOP2022 #siopambassador
Tweet media one
0
6
23
@venkymd
Venky
11 months
HDMTX administered without serum monitoring by extending hydration, leucovorin rescue (6 doses) and serum creatinine. @deepakbansaldr1 Urine PH not monitored. 17% had increase in create by 1.25 times. No dialysis. Mortality 1% due to sepsis. #SIOP2023 #SIOPambassador
1
2
23